[Latest Research Findings on Prediction of Preeclampsia in Pregnant Women Based on Analysis of Cell-Free RNA in Peripheral Blood]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Nov;53(6):1016-1020. doi: 10.12182/20220860104.
[Article in Chinese]

Abstract

Preeclampsia gravely threatens the health of mothers and infants. At present, treatment based on the relevant mechanisms of pathogenesis is still not available, and there is no independent reliable clinical index for early prediction of preeclampsia. According to recent studies, analysis of the cell-free RNA in the peripheral blood of pregnant women has shown that testing certain cell-free RNA levels can help predict in advance the occurrence of preeclampsia before clinical symptoms appear. In this paper, we described the status of research and progress in using maternal cell-free RNA analysis in predicting preeclampsia. In addition, we stated that cell-free RNA in peripheral blood may become a promising, real-time and non-invasive monitoring method that can be used to explore the mechanisms of pathogenesis and pathophysiology of preeclampsia and to identify different subtypes of preeclampsia.

子痫前期严重影响母婴健康,目前缺乏基于相关发病机制基础上的治疗方法,亦无独立可靠的早期预测子痫前期的临床指标。近期有研究表明通过对孕妇外周血游离RNA的分析发现,游离RNA检测可以在临床症状出现前提前预测子痫前期的发生。本文对于母体中游离RNA分析用于预测子痫前期的研究现状与进展进行阐述,同时指出外周血游离RNA分析可能会成为一种具有潜力、实时、无创的监测手段,可用于探索子痫前期发病机制、病理生理变化以及识别子痫前期的不同亚型。

Keywords: Cell-free RNA; Cell-free fetal RNA; Maternal cell-free RNA; Prediction of preeclampsia.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cell-Free Nucleic Acids*
  • Family
  • Female
  • Humans
  • Infant
  • Pre-Eclampsia* / diagnosis
  • Pregnancy
  • Pregnant Women

Substances

  • Cell-Free Nucleic Acids